Searched for
GSK EARNINGS ANNOUNCEMENT
Why is the US stock market crashing today? S&P 500 erases all gains and wipes out $1.3 trillion in 2 hours as Nasdaq and Dow turn sharply lower - Tech stocks and chip sector collapseThe US stock market crash today caught many investors off guard. Early gains quickly vanished as the S&P 500 erased more than $1.3 trillion...- US stocks: US market rises as tech shares gain, Middle East tensions easeWall Street indexes opened higher on Tuesday, driven by a second consecutive day of gains for chipmakers. Easing Middle East tensions also ...
- Haleon Appoints Former Castrol MD Kedar Lele as India Subcontinent PresidentHaleon has appointed Kedar Lele as president, India subcontinent, succeeding Navneet Saluja. Lele, formerly managing director of Castrol In...
- HUL a top pick in spite of near-term uncertaintiesAnalysts said the share valuations, measured by Price to Earnings (P/E) ratio, at almost 75 times are pricey, but the premium valuations wi...
- Minority investors to gain from GSK’s strategic reviewGSK CH’s sales are down from Rs 4,683 crore in FY14 to Rs 3,986 crore in FY17.
- Low sales of Horlicks in India partially offset GSK Healthcare's growthLow sales of Horlicks in India partially offset GlaxoSmithKline Healthcare’s good growth in most regions across the world in the quarter en...
- GSK Pharma profit up 6.53% at Rs 102.85 cr in Jan-Mar quarterGlaxoSmithKline Pharmaceuticals today reported 6.53 per cent increase in standalone net profit at Rs 102.85 crore for the Jan-March quarter.
- Doubts grow over GlaxoSmithKline's $6 bln capital return planwith the drugmaker's dividend under pressure following several years of stagnant growth, some believe it might make more sense to cancel th...
- GSK Pharma open offer begins today; stock hits 52-week highGSK Pharma continued to attract investor attention after its UK-based parent company GlaxoSmithKline’s voluntary open offer started today.
- Domestic pharma companies may gain as MNCs set to swallow bitter marketing pillA cautious strategy adopted by MNCs in promoting medicines could affect MNCs, including GSK, and impact their growth prospects in the India...
- $1 billion bet: GSK Pharma a short-term sell, long-term buy, say expertsThe stock is at rich valuations despite low sales and profit growth. The open offer by its parent firm is attractively priced, say experts.
- GSK Pharma rallies 20% as parent initiates open offerThe parent of GlaxoSmithKline Pharmaceuticals Ltd plans to increase its stake from 50.7 per cent to up to 75 per cent at an offer price of ...
- GlaxoSmithKline Q3 Net declines 33.73 per cent to Rs 100.95 crThe company had posted a standalone net profit of Rs 152.34 crore in the same period previous fiscal, GSK Pharma said in a filing with the ...
- GlaxoSmithKline Consumer Healthcare lines up 5,222 crore share buyback offerThe UK-based company plans to raise stake in Indian unit by 31.8 per cent through an open offer at a 28 per cent premium.
- UK-based healthcare major GlaxoSmithKline to invest Rs 5,220 cr in India subsidiaryGlaxoSmithKline today announced plans to infuse about Rs 5,220 crore in its Indian subsidiary GSKCH by increasing stake to 75% from 43.2% a...
- Why open offer announced by overseas parent of GSK Consumer Healthcare may not be successfulInvestors may not want to part with their stake in a fast moving consumer goods business in an emerging market like India.
- GSK to raise stake in GlaxoSmithKline Consumer Healthcare via open offerGlaxoSmithKline plans to raise its stake in its Indian consumer products arm to 75 per cent from 43.16 per cent through an open offer.
- GlaxoSmithkline Consumer Q2 net up 29% at Rs 107 croreThe company had reported a net profit of Rs 82.46 crore for the same period of previous year.
- GlaxoSmithKline reports Q2 loss on legal costsGlaxoSmithKline, the world's second-largest pharmaceutical company by revenue, on Wednesday reported a loss of 304 million pounds ($464 mil...
- GlaxoSmithKline to slash costs, jobs as profits dropBritish pharmaceutical giant GlaxoSmithKline said on Wednesday it would cut jobs and costs as it blamed a fall in third-quarter profits on ...
Load More
